A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
255 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Local Institution - 0093
Buenas Aires, Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0082
Mar del Plata, Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0097
Rosario, Santa Fe Province, Argentina
Not, yet, recruiting - Local Institution - 0078
Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0094
Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - 0761
Buenos Aires, Argentina
Not, yet, recruiting - Instituto de Investigaciones Clínicas Córdoba S.A.
Córdoba, Argentina
Recruiting - Local Institution - 0313
Córdoba, Argentina
Not, yet, recruiting
- Gosford Hospital
Gosford, New South Wales, Australia
Recruiting - Nepean Hospital
Penrith, New South Wales, Australia
Recruiting - Lyell Mcewin Hospital
Elizabeth Vale, South Australia, Australia
Recruiting - Grampians Health
Ballarat Central, Victoria, Australia
Recruiting - Local Institution - 0458
Epping, Victoria, Australia
Not, yet, recruiting - Joondalup Health Campus
Joondalup, Western Australia, Australia
Recruiting - Local Institution - 0451
Wentworthville, Australia
Not, yet, recruiting
- Local Institution - 0190
Innsbruck, Austria
Not, yet, recruiting - Local Institution - 0192
Linz, Austria
Not, yet, recruiting - Local Institution - 0207
Vienna, Austria
Not, yet, recruiting
- Local Institution - 0906
Brasschaat, Antwerpen, Belgium
Not, yet, recruiting - Local Institution - 0122
Anderlecht, Bruxelles-Capitale, Région de, Belgium
Not, yet, recruiting - Local Institution - 0111
Charleroi, Hainaut, Belgium
Not, yet, recruiting - Local Institution - 0714
Genk, Limburg, Belgium
Not, yet, recruiting - Local Institution - 0120
Ghent, Oost-Vlaanderen, Belgium
Not, yet, recruiting - Local Institution - 0117
Sint-Niklaas, Oost-Vlaanderen, Belgium
Not, yet, recruiting - Local Institution - 0116
Leuven, Vlaams-Brabant, Belgium
Not, yet, recruiting
- Local Institution - 0615
Teresina, Piauí, Brazil
Not, yet, recruiting - Local Institution - 0498
Natal/RN, Rio Grande do Norte, Brazil
Not, yet, recruiting - Local Institution - 0619
Porto Alegre, Rio Grande do Sul, Brazil
Not, yet, recruiting - Local Institution - 0535
Barretos, São Paulo, Brazil
Not, yet, recruiting - Local Institution - 0538
São José do Rio Preto, São Paulo, Brazil
Not, yet, recruiting - Local Institution - 0912
São Paulo, Brazil
Not, yet, recruiting
- Local Institution - 0736
Haskovo, Bulgaria
Not, yet, recruiting - Local Institution - 0551
Rousse, Bulgaria
Not, yet, recruiting - Local Institution - 0732
Sofia, Bulgaria
Not, yet, recruiting - Local Institution - 0826
Sofia, Bulgaria
Not, yet, recruiting - Local Institution - 0838
Sofia, Bulgaria
Not, yet, recruiting
- Local Institution - 0337
Ottawa, Ontario, Canada
Not, yet, recruiting - St. Marys Hospital Center
Montreal, Quebec, Canada
Recruiting - Iucpq
Québec, Canada
Recruiting
- Local Institution - 0910
Antofagasta, AN, Chile
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Mar 2026
- Primary completion
- 18 Sept 2030
- Completion
- 31 Dec 2033
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 850
- Registry id
- NCT07361497
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.